FeCl3-DMF complex as efficient catalyst for the synthesis of 6-acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones by Guenadil, F.
Bull. Chem. Soc. Ethiop. 2019, 33(3), 579-585.                                                             ISSN 1011-3924 
 2019 Chemical Society of Ethiopia and The Authors                                           Printed in Ethiopia              
DOI: https://dx.doi.org/10.4314/bcse.v33i3.18 
 
__________ 
*Corresponding author. E-mail: guendouda@yahoo.fr 
This work is licensed under the Creative Commons Attribution 4.0 International License 
SHORT COMMUNICATION 
 
FeCl3-DMF COMPLEX AS EFFICIENT CATALYST FOR THE SYNTHESIS OF 
6-ACYL-2(3H)-BENZOXAZOLONES AND 6-ACYL-2(3H)-BENZOTHIAZOLONES 
 
Faouzi Guenadil* 
 
Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, University of 
Chadli Bendjedid El Tarf-36000, Algeria 
 
(Received November 12, 2018; Revised April 20, 2019; Accepted June 5, 2019) 
 
ABSTRACT. FeCl3-DMF complex has been tested on Friedel-Crafts reaction of 2(3H)-benzoxazolone and 
2(3H)-benzothiazolone with acid chlorides and anhydrides as acylating agents. In these conditions, the 6-acyl-
2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones were obtained in yields ranging from 52 to 89%. 
Among the various commonly catalysts; AlCl3-DMF, ZnCl2-DMF and PPA, explored in this study, the best 
conditions using FeCl3-DMF were found the most convenient one 
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INTRODUCTION 
 
The 6-acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones derivatives, in particular 
are interesting, with anti-inflammatory, analgesic, antiepiliptic and antiviral properties. They are 
important building block in organic synthesis and in the design of new pharmacophores [1-15]. 
Due to their wide range of application, the syntheses of these derivatives by Friedel-Crafts 
acylation reaction have received great deal of attention [16-23]. In the literature, the most 
straight forward protocols using polyphosphoric acid (PPA), and Lewis acids such as aluminium 
chloride (AlCl3) and zinc chloride (ZnCl2) in N,N-dimethylformamide (DMF) as solvent, with 
carboxylic acids, acid chlorides or  anhydrides have been reported [24-29].  
    Moreover, the Friedel-Crafts acylation using these conditions, generally involve the use of a 
large excess of catalysts and after aqueous work-up a large of amount of toxic waste is 
generated [24-29]. During recent years, the ferric chloride (FeCl3) catalyst has been used as a 
catalyst in several organic transformations with excellent yields and great regioselectivity due to 
its low cost, ease of use, and environmental friendly properties [30-38]. On the other hand, it has 
been known that ferric chloride forms a complex with N,N-dimethylformamide by interaction 
with the carbonyl oxygen [39]. Previously, we reported the I2-N,N-dimethylformamide complex 
as useful catalyst in the Friedel-Crafts acylation of aromatic substrates [40]. In the work 
reported here, we use the ferric chloride-N,N-dimethylformamide complex (FeCl3-DMF) as a 
potential catalyst in the Friedel-Crafts acylation of 2(3H)-benzoxazolone and 2(3H)-
benzothiazolone substrates with acid chlorides and anhydrides as acylatings agents for the first 
time. 
EXPERIMENTAL 
All reactions were monitored by thin layer chromatography using Merck TLC silica gel 60 F254. 
Melting points were measured in open capillary tubes on an Electro thermal-apparatus. The IR 
spectra were obtained on a Perkin-Elmer 457 spectrometer using KBr pellets. 1H and 13C NMR 
spectra were recorded on a Brucker 400 spectrometer using DMSO-D6 or CDCl3 as solvent and 
(TMS) as an internal standard.  
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General procedure using FeCl3-DMF complex for the acylation of 2(3H)-benzoxazolone and 3-
methyl-2(3H)-benzoxazolone. A mixture of FeCl3 (38.92 g, 0.24 mol) and DMF (4.7 mL, 0.066 
mol) were placed in a three neck round bottom flash (250 mL). The flask was then equipped 
with a reflux condenser with a CaCl2 tube, and a mechanical stirrer. The flash was then placed in 
a oil bath thermostated at 90 °C. (0.04 mol) of 2(3H)-benzoxazolone or 3-methyl-2(3H)-
benzoxazolone was added in portions. When the mixture was uniformly mixed, (0.06 mol) of 
acid chloride or acid anhydride was then added dropwise, and the temperature was subsequently 
raised to 170 °C under stirring for 3 hours. The products were isolated by addition of ice water. 
The precipitate was stirred for 1 h, collected by filtration, dried and crystallized.  
 
General  procedure using FeCl3-DMF complex for the acylation of  2(3H)-benzothiazolone and 
3-methyl-2(3H)-benzothiazolone. A mixture of FeCl3 (38.92 g, 0.24 mol) and DMF (4.7 mL, 
0.066 mol) were placed in a three neck round bottom flash (250 mL). The flask was then 
equipped with a reflux condenser with a CaCl2 tube, and a mechanical stirrer. The flash was 
then placed in a oil bath thermostated at 90 °C. (0.04 mol) of 2(3H)-benzothiazolone or 3-
methyl-2(3H)-benzothiazolone was added in portions. When the mixture was uniformly mixed, 
(0.06 mol) of acid chloride or acid anhydride was then added dropwise, and the temperature was 
subsequently raised to 170 °C under stirring for 3 hours. The products were isolated by addition 
of ice water. The precipitate was stirred for 1 h, collected by filtration, dried and crystallized. 
The present products demonstrate the procedure. 
 
6-Benzoyl-2(3H)-benzoxazolone (3). Yield: 72%; m.p. 169-170 °C; IR (KBr, cm-1) ν: 3140 
(NH), 1780 (CO), 1640 (CO); 1610 (C=C).  1H-NMR (DMSO-d6, 400 MHz) δ: 7.22 (d, 1H, H-
4, J = 7.99 Hz), 7.54-7.72 (m, 7H, H-5, H-7, C6H5), 12.07 (s, 1H, NH); 
13C-NMR (DMSO-d6, 
400 MHz): 107.75, 108.81, 125.74, 126.95, 127.84, 129.31, 130.76, 133.22, 135.89, 141.67 
(aromatic carbons), 152.82 (CO), 192.82 (CO).  
 
6-Benzoyl-2(3H)-benzothiazolone (13). Yield: 74%; m.p. 216-217°C; IR (KBr, cm-1) ν: 3240 
(NH), 1667 (CO), 1638 (CO), 1618 (C=C). 11H-NMR (DMSO-d6, 400 MHz) δ: 7.24 (d, 1H, H-
4, J = 7.88 Hz, C6H3), 7.70-7.95 (m, 7H, H-5, H-7, C6H5), 12.19 (s, 1H, NH); 
13C-NMR 
(DMSO-d6, 400 MHz): 111.35, 123.61, 124.84, 128.61, 128.96, 129.41, 131.38, 132.32, 137.37, 
140.22 (aromatic carbons), 170.34 (CO), 198.71 (CO).  
 
RESULTS AND DISCUSSION 
 
In order to optimize the experimental conditions, the activity of FeCl3-DMF catalyst was first 
explored in the acylation of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone, with benzoyl 
chloride. Using the FeCl3-DMF complex, after various attempts, 6-benzoyl-derivatives were 
obtained with 68 and 69% yields at 170 °C after 3 hours. It is also mentioning that, the best 
yields were obtained when the amount of FeCl3  was in the range of 6 equivalents with respect to 
0.1 mol equivalent of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone and 0.15 equivalent of 
benzoyl chloride as acylating agent. 
It is clear that the FeCl3 cannot be considered, in such conditions, as a catalyst. It is 
previously reported that in the Friedel-Crafts acylation using AlCl3-DMF catalyst, the formation 
of a complex between AlCl3, N,N-dimethylformamide involving the π and the n electrons of the  
heterocycles [25-27].  In these conditions, 2(3H)-benzoxazolone and 2(3H)-benzothiazolone can 
be acylated only when the amount of AlCl3  was in the range of  7-11 equivalents [25-27]. As 
illustrated in Scheme 1, we propose a mechanism which is a complex formation of FeCl3-DMF. 
When dissolved in DMF, FeCl3 has the possibility to interact with the oxygen atom to generate 
equilibration between the free species and the Lewis salt stabilized by mesomery.   
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Scheme 1. Proposed mechanism of FeCl3-DMF complex formation. 
 
Table 1. 6-Acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones derivatives under optimized 
conditions. 
 
Compound X R1 R2 M.p. (°C)
a Yieldb 
1 O H CH3 227-228 68 
2 O CH3 CH3 167-168 73 
3 O H C6H5 169-170 72 
4 O CH3 C6H5 147-148 86 
5 O H 2-C4H3O 233-234 63 
6 O CH3 2-C4H3O 140-141 77 
7 O H CH2CH2COOH 218-219 52 
8 O CH3 CH2CH2COOH 179-180 63 
9 O H 2-COOH-C6H5 243-244 53 
10 O CH3 2-COOH-C6H5 210-211 58 
11 S H CH3 190-191 69 
12 S CH3 CH3 145-146 75 
13 S H C6H5 216-217 74 
14 S CH3 C6H5 147-148 89 
15 S H 2-C4H3S 223-224 62 
16 S CH3 2-C4H3S 124-125 69 
17 S H CH2CH2COOH 241-242 56 
18 S CH3 CH2CH2COOH 226-227 68 
19 S H 2-COOH-C6H5 236-237 55 
20 S CH3 2-COOH-C6H5 221-222 60 
aMelting point. bIsolated yield after crystallization. 
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Scheme 2. Acylation of 2(3H)-benzoxazolone, 2(3H)-benzothiazolone using FeCl3-DMF 
catalyst. 
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As shown in Table 1, we have exemplified the versality of our catalyst for different cases. 
Good to excellent yields were observed. It should also be noted that the yields of N-methyl-
derivatives are higher than for 2(3H)-benzothiazolone and 2(3H)-benzoxazolone. This may be 
probably due to the hydrogen mobility of the heterocycles [23]. Using these conditions, we have 
produced a number of 6-acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones using 
acid chlorides and anhydrides (Scheme 2). 
The efficiency and applicability of these conditions were compared with reported methods 
commonly used for the preparation of 6-acyl-derivatives (Table 2) [24-27, 29]. As Table 2 
demonstrates, the behavior of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone in the presence 
of FeCl3-DMF catalyst appears to be parallel to that in the case of AlCl3-DMF catalyst and in 
our method which afforded the best results [24-29]. We have exemplified the versality of our 
catalyst for different cases. Good to excellent yields were observed for aliphatic and aromatic 
acid chlorides or anhydrides.  
These results can probably due to the rate of formation of the complex FeCl3-DMF in the 
initial stage was greater for FeCl3 due to its high melting point and its simple decomposition 
complex witch permit the reactive intermediate to be formed under the reaction conditions 
compared with other Lewis acids used.   
 
Table 2. The comparative yields of 6-acyl-derivatives using the present method versus the reported 
methods. 
 
Compound X R1 R2 
Comparative yields (%) 
PPAa AlCl3-DMF
b ZnCl2-DMF
c FeCl3-DMF
 
1 O H CH3 62 65 59 68 
2 O CH3 CH3 63 70 67 73 
3 O H C6H5 58 67 65 72 
4 O CH3 C6H5 69 76 73 86 
5 O H 2-C4H3O - 61 58 63 
6 O CH3 2-C4H3O - 71 58 77 
7 O H CH2CH2COOH - 48 23 52 
8 O CH3 CH2CH2COOH - 61 32 63 
9 O H 2-COOH-C6H5 - 49 24 53 
10 O CH3 2-COOH-C6H5 - 53 33 58 
11 S H CH3 61 66 60 69 
12 S CH3 CH3 65 73 69 75 
13 S H C6H5 65 69 63 74 
14 S CH3 C6H5 72 79 75 89 
15 S H 2-C4H3S - 58 49 62 
16 S CH3 2-C4H3S - 62 58 69 
17 S H CH2CH2COOH - 52 29 56 
18 S CH3 CH2CH2COOH - 58 39 68 
19 S H 2-COOH-C6H5 - 51 47 55 
20 S CH3 2-COOH-C6H5 - 55 44 60 
Methods: (a) PPA (120 g), carboxylic acids (0.06 mol), 3 h, 100 °C. (b) AlCl3 (0.36 mol) in 7.1 mL of DMF, acid 
chlorides or anhydrides (0.06 mol), 3 h, 85 °C ; (c) ZnCl2 (0.32 mol) in 6.25 mL of DMF, acid chlorides or 
anhydrides (0.06 mol), 3 h, 135 °C. 
CONCLUSION 
We developed an efficient method using FeCl3-DMF complex for the acylation of 2(3H)-
benzoxazolone and 2(3H)-benzothiazolone. This reaction take place at 170°C with a variety of 
acid chlorides or anhydrides to yield 6-acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-
benzothiazolones in excellent yields rangring from 52 to 89%.  
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